Pharmaceutical - Inovio Pharmaceuticals


Current filters:

Inovio Pharmaceuticals

Popular Filters

Inovio announces new additions to senior management team

Inovio announces new additions to senior management team


US drug developer Inovio Pharmaceuticals has expanded its senior management team with two appointments…

BoardroomImmunologicalsInovio PharmaceuticalsPharmaceuticalUSA

Roche in up to $422.5 million deal with Inovio Pharma


Swiss drug major Roche (ROG: SIX) has signed an exclusive, worldwide license agreement with US drug developer…

Anti-viralsINO-1800INO-5150Inovio PharmaceuticalsLicensingOncologyPharmaceuticalRoche

PATH MVI links with Inovio on malaria vaccines and delivery technology


The USA-based PATH Malaria Vaccine Initiative (MVI) has announced a follow-on collaboration with drugmaker…

Inovio PharmaceuticalsPharmaceuticalResearchTropical diseasesVaccines

Biotron shares leap 29% on hepatitis C Ph IIa positive results; Inovio advances hepatitis vaccines


Australian firm Biotron (ASX: BIT) has received some strong support in the first couple of hours of market…

Anti-viralsBiotronInovio PharmaceuticalsLicensingPharmaceuticalResearchVaccinesVGX International

Back to top